North Carolina Facility of Glenmark Pharma Gets US FDA OAI Status
Glenmark Pharmaceuticals Limited has announced that the company has received Official Action Indicated (OAI) status from the US Food and Drug Administration (USFDA) for the Monroe, North Carolina (USA) facility. The OAI classification implies the inter-alia that the US FDA might withhold the approval of any pending product applications, and the supplements filed from the […]
Continue Reading